Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

5.2K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

10.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

7.4K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.4K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

15.3K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.3K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

12.2K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
12.2K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

3.3K
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An engineered viral RNA degrader on mitochondrial surface that mitigates RNA virus infection.

Nature communications·2026
Same author

PRKN activation for mitophagy requires an NME3-regulated phosphatidic acid signal that separates mitochondria from endoplasmic reticulum tethering.

Autophagy·2026
Same author

Cytoskeleton reorganization induced by a novel K6-K14 keratin fusion promotes cancer stemness and cellular plasticity via cGAS-STING selection.

Oncogenesis·2026
Same author

Targeting Heparanase Attenuates Podocyte Injury Induced by Puromycin Aminonucleoside.

Journal of cellular physiology·2025
Same author

Molecular evolution of driver mutations in cancer with microsatellite instability and their impact on tumor progression: Implications for precision medicine in patients with UCEC.

Computers in biology and medicine·2025
Same author

Glutathione determines chronic myeloid leukemia vulnerability to an inhibitor of CMPK and TMPK.

Communications biology·2024

Related Experiment Video

Updated: May 6, 2026

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate
11:31

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Published on: September 18, 2013

9.6K

Ser1333 phosphorylation indicates ROCKI activation.

Hsiang-Hao Chuang, Shao-Wei Liang, Zee-Fen Chang1

  • 1Institute of Biochemistry and Molecular Biology, National Yang-Ming University, No, 155, Sec, 2, Linong St, Taipei 11221, Taiwan. zfchang@ym.edu.tw.

Journal of Biomedical Science
|October 31, 2013
PubMed
Summary

Researchers identified a specific phosphorylation site (Ser1333) on Rho-associated protein kinase I (ROCKI) that indicates its active status. This discovery enables the development of tools to distinguish between active ROCKI and ROCKII in biological samples.

More Related Videos

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
11:23

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein

Published on: June 30, 2019

6.0K
Oligopeptide Competition Assay for Phosphorylation Site Determination
09:16

Oligopeptide Competition Assay for Phosphorylation Site Determination

Published on: May 18, 2017

7.8K

Related Experiment Videos

Last Updated: May 6, 2026

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate
11:31

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Published on: September 18, 2013

9.6K
Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
11:23

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein

Published on: June 30, 2019

6.0K
Oligopeptide Competition Assay for Phosphorylation Site Determination
09:16

Oligopeptide Competition Assay for Phosphorylation Site Determination

Published on: May 18, 2017

7.8K

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Rho-associated protein kinase (ROCK) isoforms, ROCKI and ROCKII, are crucial for cytoskeletal regulation and cellular processes.
  • ROCKI and ROCKII functions are likely non-redundant, but differentiating their activation states in samples is challenging.
  • Previous work identified ROCKII's Ser1366 phosphorylation site as sensitive to inhibition.

Purpose of the Study:

  • To identify the activity-dependent phosphorylation site in ROCKI.
  • To develop reagents for detecting individual ROCK isoform activation.

Main Methods:

  • Investigated phosphorylation sites in ROCKI sensitive to inhibition.
  • Developed and validated a ROCKI pSer1333-specific antibody.
  • Correlated ROCKI phosphorylation with downstream effectors like myosin II light chain phosphorylation.

Main Results:

  • Identified Ser1333 as the ROCKI phosphorylation site sensitive to inhibition.
  • Developed a ROCKI pSer1333-specific antibody that does not cross-react with phosphorylated ROCKII.
  • Demonstrated that ROCKI S1333 phosphorylation correlates with myosin II light chain phosphorylation upon RhoA stimulation.

Conclusions:

  • Active ROCKI is phosphorylated at the Ser1333 residue.
  • Phospho-specific antibodies for ROCKI (pSer1333) and ROCKII (pSer1366) allow discrimination of their individual active states.
  • These antibodies provide a valuable tool for studying ROCK isoform-specific roles in cells and tissues.